Astellas

Astellas's reported carbon emissions

Astellas, a pharmaceutical preparation manufacturing company headquartered in Japan, is actively engaged in climate action. For the fiscal year 2024, Astellas reported total greenhouse gas (GHG) emissions of approximately 1.38 billion kg CO2e. This figure comprises Scope 1 emissions of about 52.2 million kg CO2e, Scope 2 emissions of approximately 55.6 million kg CO2e, and substantial Scope 3 emissions totalling around 1.28 billion kg CO2e. The largest contributors to their Scope 3 footprint are purchased goods and services, accounting for roughly 1.08 billion kg CO2e. Astellas has set ambitious climate targets aligned with a 1.5°C trajectory. These include a commitment to achieve Net Zero GHG emissions by 2050. More immediately, the company aims to reduce its Scope 1 and 2 GHG emissions by 63% by fiscal year 2030, using fiscal year 2015 as the base year. Furthermore, Astellas plans to reduce its Scope 3 GHG emissions by 37.5% by fiscal year 2030, also referencing fiscal year 2015 as the baseline, aligning with a well-below 2°C pathway. Emissions data for Astellas is directly reported and not cascaded from a parent organisation.